Camp4 Therapeutics (CAMP) Other Operating Expenses (2025)
Camp4 Therapeutics (CAMP) reported Other Operating Expenses of $55.3 million for Q4 2025, up 11086.03% sequentially from $494000.0 in Q3 2025.
Camp4 Therapeutics (CAMP) Other Operating Expenses (2025) Analysis & Trends
Camp4 Therapeutics (CAMP) has 1 years of Other Operating Expenses data on file, last reported at $55.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $55.3 million; the trailing twelve-month figure through Mar 2026 stood at $55.8 million (changed N/A YoY), and the FY2025 full-year result was $55.8 million, changed N/A from the prior year.
- Other Operating Expenses climbed to $55.3 million in Q4 2025, from $494000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $55.3 million in Q4 2025 to a low of $494000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Camp4 Therapeutics | 195.78 Mn | 195.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.26 Mn |
| Sep 30, 2025 | 494,000.00 |